查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012825

Arthroscopy Devices Market by Product Type, Visualization Systems, Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，关节镜医疗设备市场价值将达到 73 亿美元，到 2026 年将成长至 79.1 亿美元，到 2032 年将达到 138.8 亿美元，复合年增长率为 9.60%。

主要市场统计数据
基准年 2025 73亿美元
预计年份：2026年 79.1亿美元
预测年份 2032 138.8亿美元
复合年增长率 (%) 9.60%

关节镜检查设备市场の基础、临床的促进要因、患者の需要パターン、および医疗意思决定者向けの戦略的优先事项に関する简洁な概要

低侵袭ソリューションへの需要が临床现场や调达决定に引き続き影响を与える中、关节镜検査用机器は现代の整形外科において依然として中心的な役割を果たしています。本概要では、基本的な临床的促进要因、利害相关人员の新たな优先事项、および机器メーカー、病院システム、外来诊疗提供者が戦略的选択を行っている业务上の背景について概説します。手术件数の増加、早期回復への重视、および特定の手术が外来手术センターへ移行していることは、关节镜検査用器具および画像诊断システムの竞合情势と业务环境を再构筑しつつあります。

可视化技术の相乗効果から器具の革新、価値に基づく医疗への统合に至るまで、关节镜诊疗を再构筑する変革的な技术的変化の探求

技术的および构造的な変化の波が、あらゆる医疗现场における关节镜検査の実施方法を変革しつつあります。可视化技术の进歩により、高解像度かつ统合されたワークフローが可能となり、手术时间の短缩と术中意思决定の向上を実现しています。同时に、洗练されたシェーバーやグラスパから、専用设计のパンチやリトラクターに至るまでの器具の革新により、手术の精度が向上し、软部组织への损伤が軽减され続けています。こうした変化に伴い、交差汚染のリスクを軽减しつつ、灭菌管理を简素化するように设计された、使い舍ておよびハイブリッド使用の器具戦略の采用が拡大しています。

最近の米国の関税措置が、サプライチェーン、筹资策略、および国境を越えた医疗设备调达动向に及ぼす累积的な影响の评価

米国で导入された最近の関税措置は、关节镜用医疗设备のサプライチェーン全体に、业务上および戦略上の连锁的な対応を引き起こしています。输入関税の引き上げや関连する政策変更は、総コストを上昇させ、购入者に筹资策略の再评価を促すことで、调达选択の枠组みに影响を与えています。このような环境下において、メーカーや经销商は、利益率と竞争上の优位性を维持するために、コスト要因に関する透明性を优先しつつ、代替的な调达体制や契约上の保护策を模索しています。

深入的細項分析揭示了产品、视觉化、应用、最终用户和销售管道的趋势，从而支援商业化和临床部署。

セグメンテーション分析は、临床ニーズ、购买行动、技术的差别化が交差する点を理解するための体系的な观点を提供します。製品タイプに基づき、市场はグラスパ、パンチ、レトラクター、シザーズ、シェーバーの各カテゴリーで调査されており、これらのカテゴリーからは明确な导入パターンが浮かび上がっています。すなわち、手术时间を短缩し、软部组织の管理を容易にする器具は、高回転の诊疗现场でより强く受け入れられている一方、特殊なツールは复雑な重组手术において依然として重要な役割を果たしています。视觉化系统に基づいて、市场はカメラ、光源、モニター、スコープに分类して调査されており、これらのコンポーネント间の统合により、画质、人间工学、および记録ワークフローを最适化するバンドルソリューションへの需要が高まっています。

南北アメリカ、欧州・中东・アフリカ、アジア太平洋地域における成长要素、偿还环境、インフラ整备状况を统合した地域别戦略的展望

地域ごとの动向は、关节镜検査用机器の规制、偿还、および普及の轨迹に强力な影响を及ぼしています。南北アメリカでは、确立された偿还経路と成熟した病院インフラが、统合型可视化プラットフォームやプレミアムな器具ラインを后押ししている一方、外来诊疗部门の急速な拡大により、コンパクトでコスト効率の高いシステムに対する高い需要が局部的に生じています。対照的に、欧州・中东・アフリカ地域では、公共调达モデルの多様性、変动する偿还制度、民间セクターによる投资の局部的な存在といった、不均一な状况が见られます。この多様性は、临床的エビデンスと弹性价格设定・サービスモデルを组み合わせた、适応性の高い商业性的アプローチを有利にしています。

一份竞争情报概览，重点介绍领先医疗设备製造商的能力、伙伴关係趋势、差异化策略和创新重点。

关节镜分野における竞合の动态は、规模、临床的信頼性、そして専门的なイノベーションのバランスを反映しています。大规模プラットフォーム志向の企业は、统合された画像诊断技术、手术器具のポートフォリオ、アフターマーケット・サービスを活用して、病院システムや外来手术センター（ASC）との长期的な関係を构筑しています。一方、小规模な専门企业は、特定の製品イノベーション、低コストの製品提供、あるいはニッチな临床的差别化を通じて竞争することが多いです。画像诊断プロバイダーと手术器具メーカー间の提携はますます一般的になっており、企业间のコラボレーションにより、互通性の向上や、大手プロバイダーとの一括调达交渉が加速しています。

业界リーダーが规制の変化に対応し、サプライチェーンを最适化し、临床导入を加速させ、永续な成长を推进するための実践的な提言

业界リーダーは、进化する临床および政策环境に合わせて、製品开発、サプライチェーンのレジリエンス、市场投入戦略を调整するための断固たる措置を讲じるべきです。第一に、サプライヤーネットワークの多様化やニアショアリング、あるいは地域的な製造伙伴关係の追求により、関税変动への曝露を軽减し、需要変动への应对力を高めることができます。第二に、临床记録、トレーニング、およびアウトカム测定をサポートする统合型可视化およびデータプラットフォームへの投资は、支払者や医疗提供者との価値に基づく対话を强化することになります。

概述了高度透明的调查方法，详细介绍了资料来源、相关人员访谈、分析框架和检验程序，以确保获得严谨的见解。

本分析は、主要な利害相关人员との対话、体系的な二次文献レビュー、および方法论的三角测量（トライアングレーション）を组み合わせた混合手法（ミックスド・メソッド）による研究アプローチに基づいています。一次データとしては、外科医、调达负责人、临床エンジニア、流通部门の干部に対する详细なインタビューを行い、実务上の意思决定基准、ワークフロー上の制约、およびサプライヤー评価を把握しました。二次文献レビューでは、査読付き临床文献、规制ガイダンス文书、および公开された政策発表を网罗し、一次インタビューで観察された临床およびコンプライアンスの动向を检验しました。

进化する关节镜検査の动向に対応する临床医、保険者、メーカー、および调达チームに向けた戦略的示唆をまとめた结论的な统合

サマリーでは、关节镜检查设备の市场环境は、并行する技术の进歩、医疗提供环境の変化、そして贸易・调达ダイナミクスの进化によって再构筑されつつあります。视认性の向上、器具の洗练、手术全期ワークフローのデジタル化は、临床面での差别化と业务効率化に向けた新たな道を开いています。同时に、関税の変更や地域ごとの规制の相违といった外部要因により、メーカーや医疗システムは、より强韧なサプライチェーンの実践と、より适応性の高い经营模式を采用することが求められています。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNVポジショニングマトリックス, 2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 业界エコシステムとバリューチェーン分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • コンシューマー洞察とエンドユーザー观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 规制コンプライアンスと标准フレームワーク
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第6章 米国の関税の累积的な影响, 2025

第七章：人工智慧的累积影响，2025年

第8章关节镜用机器市场：製品タイプ别

  • 关节镜
  • 体液管理系统
  • 刮鬍系统
  • 高周波（RF）アブレーションシステム
  • 视觉化系统

第9章关节镜用机器市场视觉化系统别

  • 相机
  • 光源
  • 监视器
  • 范围

第十章：关节镜设备市场：依应用领域划分

  • 踝
  • 弯头
  • 髋关节
  • 膝盖
  • 肩膀
  • 手腕

第11章关节镜用机器市场：エンドユーザー别

  • 医院及门诊手术中心
  • 整形外科诊所

第12章关节镜用机器市场：销售管道别

  • 直销
  • 销售代理
  • 线上销售

第十三章：关节镜设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第14章关节镜用机器市场：グループ别

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：关节镜设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国关节镜设备市场

第十七章：中国关节镜设备市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • ハーフィンダール・ハーシュマン指数（HHI）
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Bioventus LLC
  • Cannuflow, Inc.
  • CONMED Corporation
  • DJO Global, Inc.
  • EndoMed Systems GmbH
  • GPC Medical Ltd.
  • Henke Sass Wolf GmbH
  • Henke-Sass, Wolf GmbH
  • Hoya Corporation
  • Johnson & Johnson
  • JOIMAX GmbH
  • Karl Storz SE & Co. KG
  • MEDICON eG
  • Medicon Health Care Private Limited
  • MedShape, Inc.
  • Richard Wolf GmbH
  • Richard Wolf GmbH
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Sklar Surgical Instruments
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4364D48956D8

The Arthroscopy Devices Market was valued at USD 7.30 billion in 2025 and is projected to grow to USD 7.91 billion in 2026, with a CAGR of 9.60%, reaching USD 13.88 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.30 billion
Estimated Year [2026] USD 7.91 billion
Forecast Year [2032] USD 13.88 billion
CAGR (%) 9.60%

Concise introduction to arthroscopy device market fundamentals, clinical drivers, patient demand patterns, and strategic priorities for healthcare decision-makers

Arthroscopy devices remain central to modern orthopedics as demand for minimally invasive solutions continues to influence clinical practice and procurement decisions. This introduction outlines the fundamental clinical drivers, emerging stakeholder priorities, and the operational context in which device manufacturers, hospital systems, and ambulatory providers are making strategic choices. Increasing procedural volumes, an emphasis on faster recovery pathways, and the shift of selected procedures to ambulatory surgical centers are reshaping the competitive and operational landscape for arthroscopy instrumentation and visualization systems.

Consequently, decision-makers must balance clinical performance, device ergonomics, and total cost of ownership when evaluating technology adoption. The convergence of improved imaging, refined instrumentation, and evolving reimbursement frameworks is prompting multidisciplinary teams to re-evaluate supplier relationships and capital deployment strategies. As a result, manufacturers and service providers are refining their value propositions to address not only clinical outcomes but also throughput, training, and lifecycle support requirements.

Exploration of transformative technological shifts reshaping arthroscopy practice, from visualization synergies to instrument innovation and value-based care integration

A wave of technological and structural change is transforming how arthroscopy is delivered across care settings. Advances in visualization are enabling higher-resolution, integrated workflows that shorten procedure times and enhance intraoperative decision-making. At the same time, instrument innovation-ranging from refined shavers and graspers to purpose-built punches and retractors-continues to improve procedural precision and reduce soft-tissue trauma. These shifts are accompanied by growing adoption of disposable and hybrid-use instrument strategies designed to mitigate cross-contamination risk while simplifying sterilization logistics.

Moreover, digital convergence is creating new opportunities for system-level efficiency. Integration of imaging, analytics, and procedural documentation into unified platforms is facilitating value-based care conversations between providers and payers. In parallel, the transition of selected procedures to ambulatory surgical centers is driving demand for compact, cost-effective systems with rapid turn-up times and straightforward maintenance. Taken together, these transformative shifts are not only technological but also operational, requiring manufacturers and health systems to coordinate across clinical, procurement, and IT functions to capture the full benefits.

Assessment of the cumulative implications of recent United States tariff actions on supply chains, procurement strategies, and cross-border device sourcing dynamics

Recent tariff measures introduced in the United States have produced a cascade of operational and strategic responses across arthroscopy device supply chains. Increased import levies and related policy changes influence procurement choice architecture by elevating landed costs and prompting buyers to re-evaluate sourcing strategies. In this environment, manufacturers and distributors are prioritizing transparency around cost drivers while exploring alternative sourcing arrangements and contractual protections to preserve margin and competitive positioning.

From a practical perspective, the cumulative impact of tariff-related disruption has accelerated regionalization efforts and encouraged investments in nearshore manufacturing and assembly. At the same time, procurement teams are negotiating extended lead times and contingency stock arrangements to maintain continuity of care. For device suppliers, the environment underscores the importance of flexible manufacturing, diversified supplier bases, and robust trade-compliance capabilities. Importantly, strategic dialogue between commercial teams and institutional purchasers is becoming more frequent as stakeholders align on risk-sharing mechanisms and long-term supply resilience.

Insightful segmentation analysis revealing product, visualization, application, end user, and sales channel dynamics that inform commercialization and clinical adoption

Segmentation analysis offers a structured lens for understanding where clinical need, purchasing behavior, and technological differentiation intersect. Based on Product Type, market is studied across Graspers, Punches, Retractors, Scissors, and Shavers, and these categories reveal distinct adoption patterns: instruments that reduce procedure time and facilitate soft-tissue management demonstrate stronger uptake in high-throughput settings, while specialized tools maintain relevance in complex reconstructions. Based on Visualization Systems, market is studied across Cameras, Light Sources, Monitors, and Scopes, and integration across these components is driving demand for bundled solutions that optimize image quality, ergonomics, and documentation workflows.

Further nuance emerges when considering clinical application. Based on Application, market is studied across Ankle, Elbow, Hip, Knee, Shoulder, and Wrist, and each anatomical focus presents unique instrumentation and visualization requirements that influence product development priorities. Based on End User, market is studied across Hospitals And Ambulatory Surgical Centers and Orthopedic Clinics, and the differential capital constraints, throughput expectations, and staffing models across these settings shape procurement criteria. Finally, Based on Sales Channel, market is studied across Direct Sales, Distributors, and Online Sales, and channel dynamics materially affect time-to-adoption, aftermarket support expectations, and margin structures. Together, these segmentation lenses inform go-to-market strategies and clinical engagement plans for product portfolios.

Regional strategic outlook synthesizing growth enablers, reimbursement landscapes, and infrastructure readiness across Americas, Europe Middle East Africa, and Asia-Pacific

Regional dynamics exert a powerful influence on regulatory, reimbursement, and adoption trajectories for arthroscopy devices. In the Americas, established reimbursement pathways and a mature hospital infrastructure favor integrated visualization platforms and premium instrument lines, while the ambulatory sector's rapid expansion creates pockets of high demand for compact, cost-efficient systems. In contrast, Europe, Middle East & Africa presents a heterogeneous mix of public procurement models, variable reimbursement, and pockets of private-sector investment; this diversity favors adaptable commercial approaches that combine clinical evidence with flexible pricing and service models.

Turning to Asia-Pacific, rapid infrastructure investment, growing surgical capacity, and a rising middle class are driving demand for both cost-competitive disposables and advanced imaging technologies. Across all regions, regulatory oversight, local manufacturing incentives, and supply chain logistics remain defining factors. Consequently, manufacturers must tailor product specifications, service offerings, and commercial tactics to align with each region's reimbursement atmosphere, clinical practice patterns, and distribution ecosystems.

Competitive intelligence snapshot highlighting company capabilities, partnership trends, differentiation strategies, and innovation focus across leading medical device players

Competitive dynamics in the arthroscopy space reflect a balance between scale, clinical credibility, and specialized innovation. Larger platform-oriented companies leverage integrated imaging, instrument portfolios, and aftermarket services to build long-term relationships with hospital systems and ASCs, while smaller specialists often compete through focused product innovation, lower-cost offerings, or niche clinical differentiation. Partnerships between imaging providers and instrument manufacturers are increasingly common, as cross-company collaboration accelerates interoperability and bundled procurement talks with large providers.

Additionally, firms that invest in surgeon education, outcomes research, and durable service contracts tend to achieve higher adoption rates, particularly when they can demonstrate improvements in throughput or reductions in total procedural cost. From a commercial perspective, companies that combine flexible channel strategies with modular product architectures are better positioned to respond to regional regulatory changes and evolving buyer preferences. Finally, aftermarket services such as instrument repair, sterilization support, and digital workflow enhancements are emerging as significant differentiators in competitive pitches.

Action-oriented recommendations for industry leaders to navigate regulatory shifts, to optimize supply chains, accelerate clinical uptake, and to drive sustainable growth

Industry leaders should take decisive steps to align product development, supply chain resilience, and go-to-market tactics with evolving clinical and policy environments. First, diversifying supplier networks and pursuing nearshoring or regional manufacturing partnerships will reduce exposure to tariff volatility and enhance responsiveness to demand fluctuations. Second, investing in integrated visualization and data platforms that support clinical documentation, training, and outcomes measurement will strengthen value-based conversations with payers and providers.

In parallel, commercial teams should refine channel strategies by combining direct engagement for large institutional accounts with distributor partnerships and selective online offerings for price-sensitive segments. Clinical evidence generation remains a priority; leaders must fund rigorous comparative studies and real-world evidence initiatives to substantiate claims about efficiency gains and improved patient outcomes. Finally, prioritizing service models that reduce total cost of ownership-such as predictable maintenance contracts, instrument lifecycle programs, and training bundles-will help sustain long-term relationships with high-value customers and capture recurring revenue opportunities.

Transparent research methodology overview detailing data sources, stakeholder interviews, analytical frameworks, and validation steps used to ensure rigorous insights

This analysis draws on a mixed-methods research approach that combined primary stakeholder engagement with systematic secondary review and methodological triangulation. Primary inputs included in-depth interviews with surgeons, procurement officers, clinical engineers, and distribution executives to capture real-world decision criteria, workflow constraints, and supplier evaluations. Secondary review encompassed peer-reviewed clinical literature, regulatory guidance documents, and open-source policy announcements to validate clinical and compliance trends observed in primary conversations.

Quantitative and qualitative findings were triangulated through iterative validation rounds, including follow-up interviews and cross-checks against regulatory filings and manufacturer technical documentation. Where relevant, scenario analysis was used to test sensitivity to policy changes and supply chain disruptions. Limitations are acknowledged: the approach emphasizes thematic rigor over exhaustive enumeration and focuses on actionable strategic insight rather than granular vendor ranking. Nevertheless, the methodological framework ensures that conclusions are grounded in practitioner experience and corroborated by authoritative sources.

Conclusive synthesis summarizing strategic implications for clinicians, payers, manufacturers, and procurement teams navigating the evolving arthroscopy landscape

In summary, the arthroscopy device landscape is being reshaped by concurrent technological advances, shifting care settings, and evolving trade and procurement dynamics. Enhanced visualization, refined instrumentation, and the digitization of perioperative workflows are creating new avenues for clinical differentiation and operational efficiency. At the same time, external forces such as tariff changes and regional regulatory variation require manufacturers and health systems to adopt more resilient supply chain practices and more adaptable commercial models.

Looking ahead, stakeholders who proactively invest in evidence generation, flexible manufacturing, and integrated service offerings will be best positioned to capture the benefits of clinical adoption while mitigating downside risk. Collaboration between clinical leaders, procurement teams, and industry partners will be essential to translate innovation into improved patient outcomes and sustainable organizational value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Arthroscopy Devices Market, by Product Type

  • 8.1. Arthroscopes
  • 8.2. Fluid Management Systems
  • 8.3. Shaver Systems
  • 8.4. Radiofrequency (RF) Ablation Systems
  • 8.5. Visualization Systems

9. Arthroscopy Devices Market, by Visualization Systems

  • 9.1. Cameras
  • 9.2. Light Sources
  • 9.3. Monitors
  • 9.4. Scopes

10. Arthroscopy Devices Market, by Application

  • 10.1. Ankle
  • 10.2. Elbow
  • 10.3. Hip
  • 10.4. Knee
  • 10.5. Shoulder
  • 10.6. Wrist

11. Arthroscopy Devices Market, by End User

  • 11.1. Hospitals And Ambulatory Surgical Centers
  • 11.2. Orthopedic Clinics

12. Arthroscopy Devices Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Sales

13. Arthroscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Arthroscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Arthroscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Arthroscopy Devices Market

17. China Arthroscopy Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Arthrex, Inc.
  • 18.6. B. Braun Melsungen AG
  • 18.7. Bioventus LLC
  • 18.8. Cannuflow, Inc.
  • 18.9. CONMED Corporation
  • 18.10. DJO Global, Inc.
  • 18.11. EndoMed Systems GmbH
  • 18.12. GPC Medical Ltd.
  • 18.13. Henke Sass Wolf GmbH
  • 18.14. Henke-Sass, Wolf GmbH
  • 18.15. Hoya Corporation
  • 18.16. Johnson & Johnson
  • 18.17. JOIMAX GmbH
  • 18.18. Karl Storz SE & Co. KG
  • 18.19. MEDICON eG
  • 18.20. Medicon Health Care Private Limited
  • 18.21. MedShape, Inc.
  • 18.22. Richard Wolf GmbH
  • 18.23. Richard Wolf GmbH
  • 18.24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.25. Sklar Surgical Instruments
  • 18.26. Smith & Nephew plc
  • 18.27. Stryker Corporation
  • 18.28. Wright Medical Group N.V.
  • 18.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTHROSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTHROSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ARTHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHAVER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHAVER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHAVER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY RADIOFREQUENCY (RF) ABLATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY RADIOFREQUENCY (RF) ABLATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY RADIOFREQUENCY (RF) ABLATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ANKLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ANKLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ANKLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY WRIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY WRIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY WRIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HOSPITALS AND AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HOSPITALS AND AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY HOSPITALS AND AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. GCC ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. G7 ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 150. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTHROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA ARTHROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA ARTHROSCOPY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)